- Title
- Asthma and Comorbid Conditions—Pulmonary Comorbidity
- Creator
- Gibson, Peter G.; McDonald, Vanessa M.; Granchelli, Ann; Olin, J. Tod
- Relation
- Journal of Allergy and Clinical Immunology : In Practice Vol. 9, Issue 11, p. 3868-3875
- Publisher Link
- http://dx.doi.org/10.1016/j.jaip.2021.08.028
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2021
- Description
- Pulmonary comorbidities can increase disease severity and health care costs associated with asthma management. Vocal cord dysfunction/inducible laryngeal obstruction is a common comorbidity that results from intermittent laryngeal obstruction. Patients describe distinct episodes of dyspnea that do not respond to bronchodilators. Inspiratory stridor is common. The gold standard diagnostic testing strategy is continuous laryngoscopy performed during exercise or irritant challenges. Dysfunctional breathing (DB) is an overarching term that describes conditions with a chronic change in the pattern of breathing that results in pulmonary and extrapulmonary symptoms. The prevalence of DB in asthma is up to 30%, and breathing retraining can improve symptoms and quality of life in people with DB and asthma. Asthma-chronic obstructive pulmonary disease overlap (ACO) refers to both asthmatics who develop fixed airflow obstruction after a history of exposure to smoke or biomass and patients with chronic obstructive pulmonary disease who have “asthmatic features” such as a large bronchodilator response, elevated levels of serum IgE, or peripheral eosinophil counts ≥300 per μL. Triple inhaler therapy with inhaled corticosteroid/long-acting beta-agonist/long-acting muscarinic should be considered in people with ACO and severe symptoms or frequent exacerbations. The clinical expression of bronchiectasis involves persistent mucus hypersecretion, recurrent exacerbations of infective bronchitis, incompletely reversible airflow obstruction, and lung fibrosis and can occur in up to 30% of adults with longstanding asthma. The treatable traits strategy is a useful model of care to manage the complexity and heterogeneity of asthma with pulmonary comorbidity.
- Subject
- asthma; chronic obstructive pulmonary disease (COPD); dysfunctional breathing; vocal cord dysfunction (VCD); inducible laryngeal obstruction (ILO); SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1461499
- Identifier
- uon:46221
- Identifier
- ISSN:2213-2198
- Language
- eng
- Reviewed
- Hits: 1026
- Visitors: 1021
- Downloads: 0